GGTLC1
geneOn this page
Also known as dJ831C21.2dJ831C21.1
Summary
GGTLC1 (gamma-glutamyltransferase light chain 1, HGNC:16437) is a protein-coding gene on chromosome 20p11.21, encoding Glutathione hydrolase light chain 1 (Q9BX51).
This gene encodes a member of the gamma-glutamyl transpeptidase (GGT) family, which are important in the metabolism of glutathione. The most ubiquitously expressed human GGT gene, GGT1, encodes a single transmembrane polypeptide that is post-translationally processed to form a heavy and a light chain. In contrast, the product of this gene only contains homology to the light chain region, and lacks a transmembrane domain. Multiple alternatively spliced variants, encoding the same protein, have been identified.
Source: NCBI Gene 92086 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 45 total
- MANE Select transcript:
NM_178311
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16437 |
| Approved symbol | GGTLC1 |
| Name | gamma-glutamyltransferase light chain 1 |
| Location | 20p11.21 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | dJ831C21.2, dJ831C21.1 |
| Ensembl gene | ENSG00000149435 |
| Ensembl biotype | protein_coding |
| OMIM | 612338 |
| Entrez | 92086 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 protein_coding
ENST00000278765, ENST00000286890, ENST00000335694, ENST00000969294
RefSeq mRNA: 2 — MANE Select: NM_178311
NM_178311, NM_178312
CCDS: CCDS13163
Canonical transcript exons
ENST00000335694 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001361149 | 23988609 | 23988779 |
| ENSE00001626580 | 23985053 | 23985362 |
| ENSE00001657900 | 23985862 | 23985974 |
| ENSE00001668150 | 23986076 | 23986203 |
| ENSE00001789079 | 23986436 | 23986645 |
| ENSE00001789545 | 23985667 | 23985780 |
Expression profiles
Bgee: expression breadth broad, 40 present calls, max score 94.11.
Top tissues by expression
101 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right lung | UBERON:0002167 | 94.11 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 92.37 | silver quality |
| upper lobe of left lung | UBERON:0008952 | 89.77 | gold quality |
| lung | UBERON:0002048 | 84.30 | gold quality |
| right testis | UBERON:0004534 | 80.37 | gold quality |
| left testis | UBERON:0004533 | 79.50 | gold quality |
| testis | UBERON:0000473 | 79.35 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 63.47 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 62.54 | gold quality |
| thyroid gland | UBERON:0002046 | 62.06 | gold quality |
| colonic epithelium | UBERON:0000397 | 45.93 | gold quality |
| body of pancreas | UBERON:0001150 | 45.04 | gold quality |
| metanephros cortex | UBERON:0010533 | 44.67 | gold quality |
| bone marrow cell | CL:0002092 | 42.56 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 41.76 | gold quality |
| duodenum | UBERON:0002114 | 41.60 | gold quality |
| pancreas | UBERON:0001264 | 40.88 | gold quality |
| kidney | UBERON:0002113 | 39.88 | gold quality |
| muscle tissue | UBERON:0002385 | 38.96 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 38.03 | silver quality |
| lymph node | UBERON:0000029 | 37.75 | silver quality |
| granulocyte | CL:0000094 | 37.41 | gold quality |
| cortex of kidney | UBERON:0001225 | 36.89 | gold quality |
| sural nerve | UBERON:0015488 | 36.66 | gold quality |
| liver | UBERON:0002107 | 36.57 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 36.22 | gold quality |
| tonsil | UBERON:0002372 | 36.18 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Cross-species orthologs
12 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ggt1b | ENSDARG00000018342 |
| danio_rerio | ggt1a | ENSDARG00000023526 |
| danio_rerio | ggt1l2.1 | ENSDARG00000075055 |
| danio_rerio | si:ch73-236c18.3 | ENSDARG00000075541 |
| danio_rerio | ggt1l2.2 | ENSDARG00000087054 |
| danio_rerio | si:ch73-59p9.2 | ENSDARG00000091254 |
| danio_rerio | si:dkey-222h21.12 | ENSDARG00000092350 |
| danio_rerio | ENSDARG00000098576 | |
| mus_musculus | Ggt1 | ENSMUSG00000006345 |
| rattus_norvegicus | Ggt1 | ENSRNOG00000047697 |
| drosophila_melanogaster | CG17636 | FBGN0025837 |
| drosophila_melanogaster | Ggt-1 | FBGN0030932 |
Paralogs (6): GGT5 (ENSG00000099998), GGT1 (ENSG00000100031), GGTLC2 (ENSG00000100121), GGT7 (ENSG00000131067), GGT6 (ENSG00000167741), GGTLC3 (ENSG00000274252)
Protein
Protein identifiers
Glutathione hydrolase light chain 1 — Q9BX51 (reviewed: Q9BX51)
Alternative names: Gamma-glutamyltransferase light chain 1, Gamma-glutamyltransferase-like activity 4, Gamma-glutamyltransferase-like protein 6
All UniProt accessions (1): Q9BX51
UniProt curated annotations — full annotation on UniProt →
Miscellaneous. Corresponds to the light chain of other gamma-glutamyltransferase family members. Has no catalytic activity.
Similarity. Belongs to the gamma-glutamyltransferase family.
RefSeq proteins (2): NP_842563, NP_842564 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000101 | GGT_peptidase | Family |
| IPR029055 | Ntn_hydrolases_N | Homologous_superfamily |
| IPR043137 | GGT_ssub_C | Homologous_superfamily |
| IPR055262 | GGT_CS | Conserved_site |
Pfam: PF01019
UniProt features (6 total): binding site 4, chain 1, active site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BX51-F1 | 93.42 | 0.85 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (1): 37 (nucleophile)
Ligand- & substrate-binding residues (4): 55; 76; 107–108; 129–130
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 54 (showing top):
GOBP_MODIFIED_AMINO_ACID_CATABOLIC_PROCESS, GOBP_LEUKOTRIENE_BIOSYNTHETIC_PROCESS, GOBP_ORGANIC_ACID_BIOSYNTHETIC_PROCESS, GOBP_SMALL_MOLECULE_BIOSYNTHETIC_PROCESS, GOBP_SULFUR_COMPOUND_BIOSYNTHETIC_PROCESS, GOBP_SULFUR_COMPOUND_CATABOLIC_PROCESS, GOBP_AMIDE_METABOLIC_PROCESS, GOBP_AMIDE_BIOSYNTHETIC_PROCESS, GOBP_LIPID_METABOLIC_PROCESS, GOBP_ORGANIC_ACID_METABOLIC_PROCESS, GOBP_LIPID_BIOSYNTHETIC_PROCESS, GOBP_GLUTATHIONE_METABOLIC_PROCESS, GOBP_FATTY_ACID_DERIVATIVE_BIOSYNTHETIC_PROCESS, GOBP_FATTY_ACID_DERIVATIVE_METABOLIC_PROCESS, GOBP_MODIFIED_AMINO_ACID_METABOLIC_PROCESS
GO Biological Process (2): glutathione catabolic process (GO:0006751), leukotriene D4 biosynthetic process (GO:1901750)
GO Molecular Function (2): glutathione gamma-glutamate hydrolase (GO:0036374), protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| glutathione metabolic process | 1 |
| modified amino acid catabolic process | 1 |
| sulfur compound catabolic process | 1 |
| leukotriene biosynthetic process | 1 |
| sulfur compound biosynthetic process | 1 |
| fatty acid derivative biosynthetic process | 1 |
| omega peptidase activity | 1 |
| threonine-type peptidase activity | 1 |
| binding | 1 |
Protein interactions and networks
STRING
444 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GGTLC1 | GGT6 | Q6P531 | 844 |
| GGTLC1 | POM121L1P | Q3SYA9 | 571 |
| GGTLC1 | ACTL10 | Q5JWF8 | 401 |
| GGTLC1 | AKR1B10 | O60218 | 372 |
| GGTLC1 | CA11 | O75493 | 356 |
| GGTLC1 | USP1 | O94782 | 349 |
| GGTLC1 | FTL | P02792 | 348 |
| GGTLC1 | GCLC | P48506 | 343 |
| GGTLC1 | TDRD10 | Q5VZ19 | 336 |
| GGTLC1 | RCE1 | Q9Y256 | 334 |
| GGTLC1 | ATAD3C | Q5T2N8 | 324 |
| GGTLC1 | POM121 | Q96HA1 | 318 |
| GGTLC1 | ABHD1 | Q96SE0 | 308 |
| GGTLC1 | TMEM130 | Q8N3G9 | 304 |
| GGTLC1 | GGT7 | Q9UJ14 | 301 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GGTLC1 | GSTA1 | psi-mi:“MI:0915”(physical association) | 0.590 |
| GGTLC1 | VPS41 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (7): GSTA1 (Affinity Capture-MS), GSTA1 (Affinity Capture-MS), RICTOR (Affinity Capture-MS), VPS41 (Affinity Capture-MS), GGTLC1 (Negative Genetic), GGTLC1 (Negative Genetic), GGTLC1 (Negative Genetic)
ESM2 similar proteins: A6NGU5, B5MD39, B6EWW8, D4B387, F8S0Z7, O35409, O77564, P07314, P07686, P0DPU3, P0DPU6, P15693, P17439, P19111, P19440, P20735, P21588, P24822, P24823, P36268, P36269, P49614, P58242, P70627, Q04609, Q05927, Q0V8L2, Q14390, Q29548, Q2KHZ8, Q501L1, Q5RFI5, Q5RFU0, Q5TYS5, Q5XIG6, Q60928, Q680I5, Q68FH4, Q6DH69, Q6GMR7
Diamond homologs: A6NGU5, B5MD39, B8NM71, D4B387, O14194, P07314, P0DPU3, P0DPU6, P18956, P19440, P20735, P36267, P36268, P36269, P54422, P63186, Q05902, Q0V8L2, Q14390, Q60928, Q680I5, Q8VYW6, Q99JP7, Q99MZ4, Q9BX51, Q9CAR5, Q9I406, Q9M0G0, Q9QWE9, Q9UJ14, Q9US04, Q9Z2A9, A6T9C8, P15557, Q05053, Q51693, Q6P531, Q6IE08, O05218, A7YWM1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
45 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 43 |
| Likely benign | 0 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
523 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:23985359:CTTC:C | acceptor_gain | 1.0000 |
| 20:23985661:GCCCA:G | donor_loss | 1.0000 |
| 20:23985662:CCCA:C | donor_loss | 1.0000 |
| 20:23985663:CCA:C | donor_loss | 1.0000 |
| 20:23985664:CACC:C | donor_loss | 1.0000 |
| 20:23985665:A:C | donor_loss | 1.0000 |
| 20:23985666:C:A | donor_loss | 1.0000 |
| 20:23985683:T:A | donor_gain | 1.0000 |
| 20:23985777:TGGC:T | acceptor_gain | 1.0000 |
| 20:23985781:C:CA | acceptor_loss | 1.0000 |
| 20:23985781:C:CC | acceptor_gain | 1.0000 |
| 20:23985782:T:G | acceptor_loss | 1.0000 |
| 20:23985857:CATA:C | donor_loss | 1.0000 |
| 20:23985858:ATAC:A | donor_loss | 1.0000 |
| 20:23985859:TACC:T | donor_loss | 1.0000 |
| 20:23985860:A:AC | donor_gain | 1.0000 |
| 20:23985861:C:CC | donor_gain | 1.0000 |
| 20:23985861:CCA:C | donor_gain | 1.0000 |
| 20:23985970:CTTCC:C | acceptor_gain | 1.0000 |
| 20:23985972:TCC:T | acceptor_gain | 1.0000 |
| 20:23985973:CC:C | acceptor_gain | 1.0000 |
| 20:23985973:CCC:C | acceptor_gain | 1.0000 |
| 20:23985974:CC:C | acceptor_gain | 1.0000 |
| 20:23985975:C:A | acceptor_loss | 1.0000 |
| 20:23985975:C:CC | acceptor_gain | 1.0000 |
| 20:23985975:C:T | acceptor_gain | 1.0000 |
| 20:23985976:T:G | acceptor_loss | 1.0000 |
| 20:23985979:G:T | acceptor_gain | 1.0000 |
| 20:23985981:CCAA:C | acceptor_gain | 1.0000 |
| 20:23985982:C:CT | acceptor_gain | 1.0000 |
AlphaMissense
1476 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:23986140:G:C | F80L | 0.984 |
| 20:23986140:G:T | F80L | 0.984 |
| 20:23986142:A:G | F80L | 0.984 |
| 20:23986113:A:C | F89L | 0.965 |
| 20:23986113:A:T | F89L | 0.965 |
| 20:23986115:A:G | F89L | 0.965 |
| 20:23986450:G:C | S54R | 0.965 |
| 20:23986450:G:T | S54R | 0.965 |
| 20:23986452:T:G | S54R | 0.965 |
| 20:23986143:G:C | D79E | 0.950 |
| 20:23986143:G:T | D79E | 0.950 |
| 20:23986448:G:A | T55I | 0.945 |
| 20:23986441:G:C | N57K | 0.943 |
| 20:23986441:G:T | N57K | 0.943 |
| 20:23986158:A:C | N74K | 0.937 |
| 20:23986158:A:T | N74K | 0.937 |
| 20:23986137:G:C | S81R | 0.925 |
| 20:23986137:G:T | S81R | 0.925 |
| 20:23986139:T:G | S81R | 0.925 |
| 20:23985243:C:A | R217S | 0.924 |
| 20:23985243:C:G | R217S | 0.924 |
| 20:23986089:A:C | N97K | 0.923 |
| 20:23986089:A:T | N97K | 0.923 |
| 20:23985244:C:A | R217M | 0.921 |
| 20:23986159:T:A | N74I | 0.916 |
| 20:23985881:A:G | I133T | 0.914 |
| 20:23986155:A:C | N75K | 0.911 |
| 20:23986155:A:T | N75K | 0.911 |
| 20:23986460:G:T | S51Y | 0.911 |
| 20:23986141:A:G | F80S | 0.910 |
dbSNP variants (sampled 300 via entrez): RS1000132813 (20:23984607 C>A,T), RS1000467372 (20:23988655 A>T), RS1000813768 (20:23988900 C>G,T), RS1001420836 (20:23987855 C>T), RS1001871991 (20:23987631 G>A), RS1002834450 (20:23986801 G>A), RS1002957677 (20:23989859 T>C), RS1003409079 (20:23990046 C>T), RS1003889999 (20:23985708 G>A,T), RS1004414180 (20:23986842 G>C), RS1004982679 (20:23990107 C>T), RS1005910615 (20:23989197 G>A,C), RS1006429299 (20:23984993 C>G), RS1006989412 (20:23988461 T>C), RS1007921238 (20:23987150 A>G,T)
Disease associations
OMIM: gene MIM:612338 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000824_9 | Erectile dysfunction and prostate cancer treatment | 8.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases methylation, increases expression | 2 |
| Valproic Acid | increases methylation, decreases expression, increases expression | 2 |
| benzo(e)pyrene | increases methylation | 1 |
| shogaol | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Calcitriol | increases expression, affects cotreatment | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Testosterone | affects cotreatment, increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): erectile dysfunction